Capital Impact Advisors’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-9,241
Closed -$291K 274
2015
Q3
$291K Hold
9,241
0.15% 219
2015
Q2
$447K Sell
9,241
-342
-4% -$14.4K 0.2% 203
2015
Q1
$416K Buy
9,583
+6,187
+182% +$222K 0.19% 207
2014
Q4
$89K Hold
3,396
0.04% 208
2014
Q3
$60 Hold
3,396
﹤0.01% 217
2014
Q2
$82K Buy
+3,396
New +$68.8K 0.06% 216

Other funds holding PGEN

Capital Impact Advisors's PGEN Position: Q4 2015 in Review

Capital Impact Advisors sold out of Precigen (PGEN) in Q4 2015, closing a stake of 9,241 shares — an estimated $291K sold.

Capital Impact Advisors first reported a position in PGEN in Q2 2014 and held it in 6 quarters. The position peaked at $447K in Q2 2015. 180 funds tracked by Wall St. Rank hold PGEN as of Q4 2015.

  • Capital Impact Advisors reported no remaining Precigen position as of Q4 2015 after selling out during the quarter.
  • Capital Impact Advisors sold 9,241 Precigen shares in Q4 2015, an estimated $291K.
  • Capital Impact Advisors first reported a position in Precigen in Q2 2014 and held it in 6 quarters.
  • Capital Impact Advisors's Precigen position peaked at $447K in Q2 2015.
  • 180 funds tracked by Wall St. Rank held Precigen as of Q4 2015.

Based on Capital Impact Advisors's 13F filing for Q4 2015, filed 11 Jan 2016.